cymbopogon citratus leaf extract oxidized은 임신 중 안전한가요?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard for CAS 84238-19-7 was identified. PubMed/CosIng searches do not reveal ingredient-specific reproductive toxicity data. Topical cosmetic use may lead to low but measurable systemic exposure due to volatile constituents (e.g., citral), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised hazard), PubChem/CosIng entries, PubMed (no ingredient-specific repro studies), EWG (ingredient profile).
Related ingredients
Frequently asked questions
- cymbopogon citratus leaf extract oxidized은 임신 중 안전한가요?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard for CAS 84238-19-7 was identified. PubMed/CosIng searches do not reveal ingredient-specific reproductive toxicity data. Topical cosmetic use may lead to low but measurable systemic exposure due to volatile constituents (e.g., citral), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised hazard), PubChem/CosIng entries, PubMed (no ingredient-specific repro studies), EWG (ingredient profile).
- cymbopogon citratus leaf extract oxidized은 모유 수유 중 안전한가요?
- No evidence of reproductive or lactation-specific toxicity for this ingredient in authoritative assessments. Systemic transfer into breastmilk is theoretical but not demonstrated for this extract; exposure scored as low (1) given potential for low systemic absorption of volatile constituents with topical use. Sources: ECHA Annex VI, PubChem, CosIng, PubMed (no specific studies).
- cymbopogon citratus leaf extract oxidized은 아기 피부에 안전한가요?
- No infant-specific toxicity data were found and no harmonised reproductive/ developmental classification applies. Because infant skin has higher permeability and surface-area-to-weight ratio and lemongrass extracts can contain absorbable volatile constituents (e.g., citral), exposure was increased by +1 for 0–3 yr (adult exposure low → infant moderate). Note: primary concern for topical use is skin sensitization (citral), not documented developmental toxicity for this extract. Sources: CosIng, PubChem, PubMed, EWG, ECHA (no harmonised classification).
- VeriMom은 cymbopogon citratus leaf extract oxidized을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 cymbopogon citratus leaf extract oxidized을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 cymbopogon citratus leaf extract oxidized 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.